Skip to main content

Table 1 Demographic information and clinical characteristics of 278 patients with MDR/RR-TB in Sichuan, China

From: Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China

Characteristic

Total cases (N = 278)

New cases (N = 211)

Re-treated cases (N = 67)

n

%

n

%

n

%

Sex

Male

214

76.98

157

74.41

57

85.07

Female

64

23.02

54

25.59

10

14.93

Age group

≤ 24

24

8.63

19

9.00

5

7.46

25–44

66

23.74

51

24.17

15

22.39

45–65

128

46.04

90

42.65

38

56.72

> 65

60

21.58

51

24.17

9

13.43

Nationality

Han nationality

271

97.48

206

97.63

65

97.01

Other

7

2.52

5

2.37

2

2.99

Occupation*

Farmer

216

78.55

159

75.71

57

87.69

Students and faculty

15

5.45

14

6.67

1

1.54

Other

44

16.00

37

17.62

7

10.77

Census registry*

Resident

243

88.36

184

87.62

59

90.77

Migrant

32

11.64

26

12.38

6

9.23

Concomitant disease*

Yes

44

16.00

33

15.71

11

16.92

No

231

84.00

177

84.29

54

83.08

Visiting hospital delay*

< 14 days

125

45.45

97

46.19

28

43.08

≥ 14 days

150

54.55

113

53.81

37

56.92

Health system delay*

< 14 days

241

87.64

187

89.05

54

83.08

≥ 14 days

34

12.36

23

10.95

11

16.92

Patient source*

Clinic visit due to symptoms

80

29.09

56

26.67

24

36.92

Tracing

63

22.91

55

26.19

8

12.31

Referral

121

44.00

91

43.33

30

46.15

Other

11

4.00

8

3.81

3

4.62

  1. Three cases had missing information regarding the census registry, concomitant disease, health system delay, visiting hospital delay, and patient source (*). MTB/RR-TB, multidrug-resistant or rifampicin-resistant tuberculosis